DR. AGARWAL'S EYE HOSP L (DRAGARWQ)

NSE: ₹5,118.60
BSE: ₹5,129.80
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Credit Rating

Re-affirmation and withdrawal of Credit Rating by CRISIL Ratings Limited with respect to the debt facilities availed by the Company is submitted.

2026-06-16 19:58:58
Announcement under Regulation 30 (LODR)-Newspaper Publication

Joint Newspaper Advertisement of the NCLT convened meetings of the Equity Shareholders, Secured Creditors and Unsecured Creditors of the Company, is submitted.

2026-06-01 18:48:19
Letter To Equity Shareholders And Creditors

Letter providing direct weblink and a Static Quick Response Code to the Notice of the Equity Shareholders and Creditors dispatched by the Company, is submitted.

2026-06-01 18:14:33
Announcement under Regulation 30 (LODR)-Scheme of Arrangement

Notice convening the meeting of the unsecured creditors of the Company pursuant to the order of the Hon'ble Tribunal, Chennai Bench, is submitted.

2026-06-01 13:16:07
Announcement under Regulation 30 (LODR)-Scheme of Arrangement

Notice convening the meeting of the Secured Creditors of the Company pursuant to the order of the Hon'ble NCLT, Chennai Bench.

2026-06-01 13:11:35
Notice Convening Meeting Of The Equity Shareholders Of The Company Pursuant To The Order Of Hon'ble NCLT, Chennai Bench

Notice convening the Meeting of the Equity Shareholders of the Company pursuant to the Order of Honb'le NCLT, Chennai Bench, is submitted.

2026-06-01 13:06:37
Corporate Action-Board approves Dividend

Declaration of Final Dividend of Rs 4/- per equity share of Rs. 10 each for the financial year ended March 31, 2026.

2026-05-20 18:35:24
Board Meeting Outcome for Consideration And Approval Of Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Declaration Of Final Dividend For The Financial Year Ended March 31, 2026

Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Declaration of Final Dividend for the financial year ended March 31, 2026, is attached

2026-05-20 18:31:10
Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2026

Audited Financial Results of the Company for the quarter and year ended March 31, 2026, is attached.

2026-05-20 18:27:13
2026-05-14 15:59:00

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 83.27 75.67 80.72 100.02 102.19 95.11 99.83 116.92 117.72 116.22 120.01 142.97
YOY Revenue Growth % 21.12% 19.09% 16.63% 28.56% 22.72% 25.69% 23.67% 16.9% 15.2% 22.2% 20.21% 22.28%
Other Income 2.29 0.95 2.46 0.40 2.28 2.31 0.10 0.80 0.68 2.77 1.57 1.96
Total Income 85.56 76.62 83.18 100.42 104.47 97.42 99.93 117.72 118.40 118.99 121.58 144.93
Total Expenses + 68.91 63.90 65.84 81.51 85.34 83.36 81.33 94.53 92.68 95.54 100.33 113.97
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 16.43 15.51 15.41 17.57 19.90 20.90 19.95 22.18 21.44 24.10 23.96 27.48
Other Expenses 34.96 31.61 32.58 40.89 41.46 38.38 37.65 45.36 44.28 46.03 51.19 58.63
Operating Profit 14.36 11.77 14.88 18.51 16.85 11.75 18.50 22.39 25.04 20.68 19.68 29.00
OPM % 17.2% 15.6% 18.4% 18.5% 16.5% 12.4% 18.5% 19.1% 21.3% 17.8% 16.4% 20.3%
Profit Before Tax + 16.65 12.72 17.34 18.91 19.13 14.06 18.60 23.19 25.72 23.45 21.25 30.96
Tax Expense 4.06 3.28 4.55 4.80 4.98 3.66 2.61 5.93 6.40 6.17 5.01 7.58
Tax % 24.4% 25.8% 26.2% 25.4% 26% 26% 14% 25.6% 24.9% 26.3% 23.6% 24.5%
Profit After Tax 12.59 9.44 12.79 14.11 14.15 10.40 15.99 17.26 19.32 17.28 16.24 23.38
EPS (Basic) 26.79 20.09 27.21 30.02 30.11 22.13 34.02 36.72 41.04 35.76 33.60 48.38

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 470.87 397.15 319.30 267.89 201.21 139.81
YOY Revenue Growth % 18.56% 24.38% 19.19% 33.14% 43.92% -
Other Income 5.82 5.09 4.97 1.76 1.26 0.81
Total Income 476.69 402.24 324.27 269.65 202.47 140.62
Total Expenses + 383.08 331.54 262.02 220.25 170.16 134.88
Employee Benefit Expense 91.68 78.32 63.78 53.26 38.51 32.17
Other Expenses 186.86 158.38 130.76 110.13 82.17 61.02
Operating Profit 87.79 65.61 57.28 47.64 31.06 4.93
OPM % 18.6% 16.5% 17.9% 17.8% 15.4% 3.5%
Profit Before Exceptional 93.61 70.70 62.25 49.40 32.31 5.73
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 93.61 70.70 62.25 49.40 32.31 5.73
Tax Expense 23.51 16.05 15.89 12.48 8.21 7.17
Tax % 25.1% 22.7% 25.5% 25.3% 25.4% 125.1%
Profit After Tax 70.10 54.65 46.36 36.92 24.10 -1.44
EPS (Basic) 147.02 116.28 98.64 78.55 51.29 -3.06

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 629.92 557.38 435.93 343.40 262.78 111.16
Property, Plant & Equipment 374.82 160.13 120.87 85.31 58.82 57.03
Capital Work in Progress 197.32 127.98 97.44 62.21 26.47 0.00
Non-Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
Goodwill 5.66 5.66 0.18 0.18 0.00 0.00
Other Intangible Assets 22.06 22.43 0.62 0.96 1.66 0.61
Current Assets + 136.54 55.94 59.83 46.54 51.23 44.07
Inventories 14.10 13.40 9.75 6.00 5.73 5.21
Trade Receivables 18.71 13.97 12.93 10.11 8.67 8.78
Cash and Cash Equivalents 6.63 11.16 32.88 27.38 28.11 21.52
Current Investments 89.06 12.63 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 346.30 209.61 157.15 113.34 78.17 54.66
Equity Share Capital 4.83 4.70 4.70 4.70 4.70 4.70
Other Equity 341.47 204.91 152.45 108.64 73.47 49.96
Non-Current Liabilities 308.78 316.73 257.84 221.52 182.49 51.97
Current Liabilities 111.38 86.98 80.77 55.08 53.35 48.60
Total Liabilities 420.16 403.71 338.61 276.60 235.84 100.57

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 145.14 94.48 89.77 69.62 56.68 33.87
Cash from Investing Activities -173.53 -132.78 -70.04 -70.61 -46.28 -10.97
Cash from Financing Activities 24.78 16.58 -14.23 0.26 -3.81 -7.60
Net Increase/Decrease in Cash -3.61 -21.72 5.50 -0.73 6.58 15.31